Is Innovassynth Inv overvalued or undervalued?

As of 19 September 2025, the valuation grade for Innovassynth Inv has moved from very expensive to risky, indicating a significant shift in its financial outlook. The company is currently assessed as overvalued, particularly given its troubling headline ratios, including a PE ratio of -254.66, an EV to EBIT of -254.60, and a ROCE of -1.89%. These figures suggest that the company is struggling to generate profits relative to its valuation.
In comparison to its peers, Innovassynth Inv stands out negatively; for instance, Bajaj Finance has a PE ratio of 35.51 and Life Insurance boasts an EV to EBITDA of 9.07, both reflecting much healthier valuations. The stark contrast in these ratios highlights the challenges Innovassynth Inv faces in the current market. Additionally, while the company's stock has outperformed the Sensex over the longer term, recent returns indicate a decline, with a YTD performance of -5.11% compared to the Sensex's 5.74%. This further reinforces the notion that Innovassynth Inv is currently overvalued in the market.